Little Rock Startup Gets Support for Bone Filler

by Arkansas Business Staff  on Monday, Feb. 4, 2019 12:00 am   1 min read

Two examples of bone filler made by NuShores Biosciences and awaiting FDA approval. (NuShores Biosciences)

Did you know a Little Rock startup recently raised $1.1 million for its company that hopes to sell bone filler?

NuShores Biosciences LLC will use some of the money it raised selling shares of the company to conduct more studies on its product in order to get approval from the Food & Drug Administration, said its CEO, Sharon Ballard.

Ballard said the company had a preliminary submission of its results to the FDA in November. “I felt like it went well,” she said. “And I was encouraged by their comments and suggestions.”

Ballard said she expects to have all the information submitted to the FDA by the third quarter of this year. Once approved, NuShores’ product could be used in the body wherever surgeons use bone filler for bone injuries, Ballard said.

The sale of shares comes after NuShores received a $1.7 million fast track grant from the Small Business Innovation Research program in August to study NuShores’ product for dental implants. NuShores has partnered in the study with Stony Brook University School of Dental Medicine in New York.

“It’s a significant award,” Ballard said. And she hopes NuShores’ product will reduce the time and costs tied to dental implants.

NuShores holds the license to manufacture and sell the bone filler product from the University of Arkansas at Little Rock, which owns the patent and the patents that are pending for the products. The University of Tennessee at Knoxville also collaborated on the product.

UA Little Rock would receive royalties from NuShores’ sales.

NuShores has four part-time employees and operates out of BioVentures, which is affiliated with the University of Arkansas for Medical Sciences in Little Rock. Ballard said she hopes NuShores finds its own offices sometime this year.

 

 

Please read our comments policy before commenting.